ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
20 announcements
Nexus Surgical and Medicare Ltd has scheduled a board meeting for November 14, 2026. The board will consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Nexus Surgical and Medicare Limited filed its quarterly Regulation 74(5) certificate from its RTA, confirming dematerialization activities for the period ended 30th September, 2026.
Shareholders approved the appointment of Mr. Anish More as Managing Director of Nexus Surgical and Medicare for a three-year term, effective September 2, 2026.
Nexus Surgical And Medicare Limited held its 35th Annual General Meeting on September 25, 2026. Shareholders discussed and voted on routine agenda items.
Nexus Surgical and Medicare Ltd clarified that recent stock price movements are purely market-driven, confirming no undisclosed information or pending corporate actions exist.
Nexus Surgical and Medicare Limited filed its Annual Report and AGM Notice for the financial year 2025-26. The document details company performance and upcoming director appointments.
Nexus Surgical and Medicare Limited has scheduled its 35th Annual General Meeting for September 25, 2026, via video conferencing. The register of members will close accordingly.
Nexus Surgical and Medicare reconstituted its Audit, Nomination & Remuneration, and Stakeholders Relationship committees. These changes were effective from September 2, 2026.
Mr. Ram Swaroop Joshi has resigned as the Managing Director of Nexus Surgical and Medicare Limited, effective September 2, 2026. He will continue as a Promoter Non-Executive Director.
Nexus Surgical approved the Directors' Report and Financial Statements at its board meeting. It also announced leadership changes and scheduled its 35th Annual General Meeting.
Nexus Surgical and Medicare Limited will hold a Board Meeting on 2nd September, 2026, to discuss the Directors' Report and AGM scheduling.
Nexus Surgical and Medicare Ltd reported revenue from operations of ₹2.5 Cr (+47.1% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q1 FY27.
Nexus Surgical and Medicare Ltd disclosed its shareholding pattern as per regulatory requirements. No financial transaction or corporate event is presented.
Nexus Surgical and Medicare Limited appointed M/s. VMRS & Co. as Internal Auditors for F.Y. 2026-27. This ensures continued regulatory compliance and internal governance.
Nexus Surgical and Medicare Ltd reported revenue from operations of ₹2 Cr (+33.3% YoY) and net profit of ₹0.2 Cr (+100.0% YoY) for Q4 FY26.
Nexus Surgical and Medicare reported total annual income of ₹7.90 Crore for FY26. The board also appointed M/s. VMRS & Co. as internal auditors.
Nexus Surgical And Medicare scheduled a board meeting for May 28, 2026. Directors will consider audited financial results for the quarter and year ended March 2026.
Nexus Surgical clarified that recent price movements are purely market-driven. The company confirmed no undisclosed price-sensitive information exists that requires disclosure to the exchange.
Nexus Surgical and Medicare Ltd submitted its quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended March 31, 2026. The report, provided by registrar Purva Sharegistry, confirms that no share certificates were received for dematerialisation during this quarter.
Nexus Surgical and Medicare Ltd reported net profit of ₹0.2 Cr (+100.0% YoY) for Q3 FY26.